From: Could cooling dialysate improve inflammatory and nutritional status of hemodialysis patients?
Item | Group A (n = 30) | Group B (n = 40) | P | |||
---|---|---|---|---|---|---|
Demographic and Clinical data | ||||||
Age (years) | 51 ± 18.15 | 51.95 ± 14.65 | 0.80* | |||
Gender | Male Female | 16 (53.3) 14 (46.7) | 23 (57.5) 17 (42.5) | 0.72# | ||
DM | 4 (13.3) | 7 (17.5) | 0.44# | |||
HTN | 18 (60) | 20 (50) | 0.40# | |||
Original disease | Diabetic nephropathy Hypertensive nephropathy Polycystic kidney disease Interstitial nephritis SLE Failed Transplantation Unknown Obstructive uropathy Chronic GN | 2 (6.7) 14 (46.7) 0 2 (6.7) 0 0 10 (33.3) 2 (6.7) 0 | 3 (7.5) 21 (52.5) 1 (2.5) 2 (5) 1 (2.5) 1 (2.5) 9 (22.5) 1 (2.5) 1 (2.5) | 0.79# | ||
HD duration(years) | 4.5 (3–7) | 3.5 (2–7) | 0.17Ω | |||
BP | DBP SBP | 139.8 ± 16.58 80.8 ± 7.43 | 137.7 ± 11.7 79.7 ± 6.29 | 0.54* 0.51* | ||
Anthropometric measurements | ||||||
BMI (kg/m2) | 29.6 ± 6.73 | 28.6 ± 5.13 | 0.45* | |||
Weight(kg) | 79.5 ± 17.33 | 78.5 ± 15.86 | 0.8* | |||
Height(m) | 163.1 ± 9.86 | 165.9 ± 8.5 | 0.21* | |||
MAC (cm) | 29.6 ± 4.55 | 28.8 ± 4.66 | 0.49* | |||
SFT (cm) | 17.7 ± 7.35 | 17.9 ± 7.65 | 0.91* | |||
MAMC (cm) | 24.9 ± 2.91 | 24.5 ± 3.8 | 0.64* | |||
MIS | 3 (2–5) | 4 (2.25–5.75) | 0.20 Ω | |||
Laboratory data | ||||||
Calcium (mg/dl) | 8.45 ± 1.1 | 8.1 ± 1.03 | 0.17* | |||
Phosphorus (mg/dl) | 5.27 ± 1.81 | 4.97 ± 1.07 | 0.48* | |||
P.T.H (pg/ml) | 583 (171–1129) | 570 (332–1106) | 0.48 Ω | |||
Albumin (g/dl) | 3.85 ± 0.35 | 3.79 ± 0.36 | 0.47* | |||
Cholesterol | 158.9 ± 38.26 | 168.2 ± 43.87 | 0.35* | |||
Hemoglobin (g/dl) | 11.5 ± 2.26 | 10.9 ± 1.72 | 0.25Ω | |||
Ferritin (ng/ml) | 1157 (604–1338) | 680 (443–932) | 0.02Ω | |||
TSAT (%) | 35 (29.5–55.5) | 35.5 (27-44.75) | 0.39 Ω | |||
ESR (mm\hr) | 25 (15-31.25) | 30 (10-44.75) | 0.75 Ω | |||
HS-CRP (mg\l) | 14.15 (5.88–21.08) | 11.55 (4.90-18.58) | 0.45 Ω | |||
IL-6 (pg\ml) | 4.4 (3.85-5) | 4.2 (3.32–4.8) | 0.31 Ω | |||
KT/V | 1.19 ± 0.32 | 1.17 ± 0.32 | 0.76 * |